Pfizer (NYSE: PFE) announced on Thursday that it would be recalling intravenous drugs that has floating matter in them, warning that the drugs could potentially kill patients that have been weakened.
The recall comes just days after U.S. regulators have warned about the drugs earlier in the week. The products, produced by Claris Lifesciences and distributed by Pfizer, are antibiotics metronidazole and ciprofloxacin as well as a drug used to prevent nausea following surgery and chemotherapy, named ondansetron.
The Food and Drug Administration warned on last Sunday that doctors and hospitals should not use the drugs because of concerns that the floating matter in the IVs may not be sterile.
Pfizer said that the non-sterility in the intravenous drugs could potentially be fatal for patients that have weakened immune systems. In addition to the company’s recall, Pfizer said that it would be halting its distribution of all sterile injectable products and IV bags licensed from Claris.
